Eli Lilly & Co.
Market cap $1.07T
$1,196.03
LLY
$1,196.03
+0.86% today
Buy with €1M virtual cash · No real money
Eli Lilly & Co. (LLY) is a publicly traded company listed on the XNYS. As of July 27, 2026, Invest's signal rates LLY a Buy, with the stock up 50% over the past year. You can practice trading LLY risk-free with €1,000,000 in virtual cash.
Key stats
As of July 27, 2026
Market Cap
$1.07T
Volume
2.0M
52-wk High
$1,249.45
52-wk Low
$623.78
Day High
$1,206.94
Day Low
$1,187.50
P/E (TTM)
52.11
Revenue (TTM)
$65.2B
EPS (TTM)
$22.95
Performance
1M
+7.1%
6M
+10.0%
1Y
+49.7%
Invest signal · LLY
BuyAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
LLY overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev +9.6%Revenue
$19BEPS (diluted)
$7.39 per shareLatest LLY news
Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?
The Motley Fool · 13h ago
2 Top Growth Stocks to Buy Right Now Without Any Hesitation
The Motley Fool · 3d ago
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
GlobeNewswire Inc. · 3d ago
iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026?
The Motley Fool · 3d ago
Which Is the Better Healthcare ETF: First Trust's High-Conviction FBT or Vanguard's Low-Cost VHT?
The Motley Fool · 3d ago
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Employees
50,000
30-Day Win Rate · LLY
14 days
9 days
Last 23 sessions
How to practice trading LLY
- 1
Use the LLY buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top LLY traders on Invest
Full leaderboardFrequently asked questions
Is LLY a good stock to buy right now?
As of July 27, 2026, Invest's signal rates LLY a Buy, based on its price trend, valuation, and fundamentals (P/E around 52.1), with the stock up 50% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading LLY risk-free first.
What is Eli Lilly & Co.'s (LLY) market cap?
Eli Lilly & Co. has a market capitalization of approximately $1.07T, on trailing-twelve-month revenue of about $65.2B.
How has LLY stock performed?
LLY is up 50% over the past year and up 10% over six months. Its 52-week range runs roughly from $623.78 to $1,249.45. Past performance doesn't predict future results.
How can I practice trading LLY for free?
On Invest you get €1,000,000 in virtual cash and can buy LLY at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare LLY with peers